| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2014 | US20140371321 Novel process for concentrating spilanthol and/or isomers and/or homologues thereof |
| 12/18/2014 | US20140371320 Compositions and methods for stimulating hair growth |
| 12/18/2014 | US20140371318 Orally-disintegrating formulations of flurbiprofen |
| 12/18/2014 | US20140371317 Silicone Resin Emulsions |
| 12/18/2014 | US20140371315 Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
| 12/18/2014 | US20140371312 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/18/2014 | US20140371309 Ophthalmic solution |
| 12/18/2014 | US20140371308 Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| 12/18/2014 | US20140371307 Sirt 1 activator including syringaresinol |
| 12/18/2014 | US20140371306 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
| 12/18/2014 | US20140371305 Mupirocin Antibiotic Composition |
| 12/18/2014 | US20140371303 Compositions and methods for glycemic control of subjects with impaired fasting glucose |
| 12/18/2014 | US20140371293 Amine Cationic Lipids and Uses Thereof |
| 12/18/2014 | US20140371292 Method for the controlled intracellular delivery of nucleic acids |
| 12/18/2014 | US20140371287 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-ethylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| 12/18/2014 | US20140371282 Controlled release pharmaceutical compositions with improved bioavailabililty |
| 12/18/2014 | US20140371280 Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration |
| 12/18/2014 | US20140371277 Compositions for treating amyotrophic lateral sclerosis |
| 12/18/2014 | US20140371262 Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment |
| 12/18/2014 | US20140371260 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 12/18/2014 | US20140371259 Compounds and methods for inhibition of ap endonuclease-1/redox factor-1 (hape1) activity |
| 12/18/2014 | US20140371258 Water-Soluble Polymer Conjugates of Topotecan |
| 12/18/2014 | US20140371257 Pharmaceutical Formulation Containing Gelling Agent |
| 12/18/2014 | US20140371254 Novel treatment of gefitinib-resistant non-small-cell lung cancer |
| 12/18/2014 | US20140371248 SMALL MOLECULE ACTIVATORS OF HslV PROTEASE FOR DEVELOPMENT OF NOVEL ANTIMICROBIALS |
| 12/18/2014 | US20140371247 Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7 |
| 12/18/2014 | US20140371243 Medical use of a dpp-4 inhibitor |
| 12/18/2014 | US20140371242 Azathioprine Oral Suspensions and Methods of Use |
| 12/18/2014 | US20140371241 Tec family kinase inhibitor adjuvant therapy |
| 12/18/2014 | US20140371238 Compounds and methods for the treatment of cystic fibrosis |
| 12/18/2014 | US20140371237 p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth |
| 12/18/2014 | US20140371236 Agent for treatment of schizophrenia |
| 12/18/2014 | US20140371235 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
| 12/18/2014 | US20140371233 COMPOSITIONS AND METHODS FOR TREATING Aß-MODULATED DISEASE OR DISORDER OR IMPROVING COGNITION IN A SUBJECT |
| 12/18/2014 | US20140371231 Methods Of Treating Dyskinesia And Related Disorders |
| 12/18/2014 | US20140371230 Heteroaryl derivatives as cftr modulators |
| 12/18/2014 | US20140371229 New therapeutic approaches for treating parkinson's disease |
| 12/18/2014 | US20140371227 Kappa opioid receptor effectors and uses thereof |
| 12/18/2014 | US20140371225 Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| 12/18/2014 | US20140371222 Triazole compounds that modulate hsp90 activity |
| 12/18/2014 | US20140371219 Thieno[3,2-d]pyrimidine derivatives having inhibitory activity for protein kinases |
| 12/18/2014 | US20140371215 1-H-Pyrrolo[2,3-b]Pyridine Derivatives |
| 12/18/2014 | US20140371213 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 12/18/2014 | US20140371211 Piroxicam Transdermal Composition to Treat Plantar Fasciitis |
| 12/18/2014 | US20140371210 Methods and compositions for rapid transbuccal delivery of active agents |
| 12/18/2014 | US20140371208 Methods of treating disease-induced ataxia and non-ataxic imbalance |
| 12/18/2014 | US20140371199 Bicyclic heterocyclic derivatives as mnk1 and mnk2 modulators and uses thereof |
| 12/18/2014 | US20140371198 Novel compounds useful for the treatment of metabolic and inflammatory diseases |
| 12/18/2014 | US20140371195 Inhibitors of histone demethylases |
| 12/18/2014 | US20140371194 Methods for the treatment of bacterial infections |
| 12/18/2014 | US20140371192 Alpha-form zinc-phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an alpha-form zinc-phthalocyanine nanowire/phenothiazine, and method for preparing same |
| 12/18/2014 | US20140371191 Oromucosal Liquid Estradiol Compositions |
| 12/18/2014 | US20140371189 Testosterone replacement therapy in animals, including dogs |
| 12/18/2014 | US20140371188 Compositions and methods for inhibiting muscle atrophy and inducing muscle hypertrophy |
| 12/18/2014 | US20140371187 Semi-solid delivery vehicle and pharmaceutical compositions |
| 12/18/2014 | US20140371186 Testosterone Combined with Anastrozole Injection Solutions |
| 12/18/2014 | US20140371185 Natural combination hormone replacement formulations and therapies |
| 12/18/2014 | US20140371184 Natural combination hormone replacement formulations and therapies |
| 12/18/2014 | US20140371183 Natural combination hormone replacement formulations and therapies |
| 12/18/2014 | US20140371182 Natural combination hormone replacement formulations and therapies |
| 12/18/2014 | US20140371181 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 12/18/2014 | US20140371180 Process for purification and isolation of estrogens |
| 12/18/2014 | US20140371179 Methods and Compositions for Treating Esophageal Diseases |
| 12/18/2014 | US20140371174 Effervescent Dosage Form |
| 12/18/2014 | US20140371173 Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk |
| 12/18/2014 | US20140371170 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 12/18/2014 | US20140371169 Aqueous iron carbohydrate complexes, their production and medicaments containing them |
| 12/18/2014 | US20140371166 Antibiotic Composition for Inhalation and Irrigation |
| 12/18/2014 | US20140371165 Identification of NSC23925 Isomers to Reverse Multidrug Resistance in Human Cancers |
| 12/18/2014 | US20140371164 Synergistic Combination Comprising Avermectins and a NSAID for Tumor Inhibition |
| 12/18/2014 | US20140371163 Combination therapy for acne vulgaris comprising administration of adapalene 0.3% gel and clindamycin/benzoyl peroxide gel |
| 12/18/2014 | US20140371162 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 12/18/2014 | US20140371159 In vitro method for modifying the depletion profile of treg cells present in a total splenocyte population of a biological sample by means of the isolation, culturing and exposure thereof to an atp and polymixin b medium |
| 12/18/2014 | US20140371157 Methods of downregulating translocated oncogene expression using bromodomain inhibitors |
| 12/18/2014 | US20140371153 Method for administering omega-conopeptide |
| 12/18/2014 | US20140371147 Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders |
| 12/18/2014 | US20140371138 Inhibitors of hepatitis c virus replication |
| 12/18/2014 | US20140371134 Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear |
| 12/18/2014 | US20140370134 Composition comprising Rhizoma Coptidis, Cortex Phellodendri and Fructus Gardeniae and For Treating Neurodegenerative Diseases |
| 12/18/2014 | US20140370130 Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partsum |
| 12/18/2014 | US20140370124 Multi-purpose anti-itch treatment |
| 12/18/2014 | US20140370123 Skin external composition comprising a sea salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 12/18/2014 | US20140370122 Methods and compositions for promoting activity of anti-cancer therapies |
| 12/18/2014 | US20140370121 Materials and method for inhibiting replication protein a and uses thereof |
| 12/18/2014 | US20140370120 Methods of Nourishing Animals |
| 12/18/2014 | US20140370118 Methods of treating malnutrition |
| 12/18/2014 | US20140370113 Hydrocortisone controlled release formulation |
| 12/18/2014 | US20140370112 Multiparticulate L-Carnitine Compositions and Related Methods |
| 12/18/2014 | US20140370110 Polymer conjugated protein micelles |
| 12/18/2014 | US20140370109 Stabilized Granules Containing Glyceryl Trinitrate |
| 12/18/2014 | US20140370108 Pharmacokinetics of S-Adenosylmethionine Formulations |
| 12/18/2014 | US20140370106 Beadlets comprising hop acid salts in a protein matrix |
| 12/18/2014 | US20140370105 Treatment of inflammatory bowel disease with 6-mercaptopurine |
| 12/18/2014 | US20140370104 Pharmaceutical formulation and method for treating acid caused gastrointestinal disorders |
| 12/18/2014 | US20140370103 Non-immunogenic delivery vehicle for betta-, gamma-, and delta-tocopherols and methods of using and making same |
| 12/18/2014 | US20140370102 Method and composition for pharmaceutical product |
| 12/18/2014 | US20140370101 2,2',6,6'-tetraisopropyl-4,4'-biphenol lipid microsphere preparations and preparation methods therefor |
| 12/18/2014 | US20140370097 Sterile pharmaceutical compositions |
| 12/18/2014 | US20140370095 Weight Loss Compositions and Methods for Appetite Suppression |
| 12/18/2014 | US20140370093 Oral antimicrobial pharmaceutical compositions |